Status:
ENROLLING_BY_INVITATION
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Steno Diabetes Center Copenhagen
BGI Europe
Conditions:
Diabetes Mellitus, Type 2
Diabetes, Gestational
Eligibility:
All Genders
18+ years
Brief Summary
The aim of TRANSLATE is to implement genetic information directly into patient care to improve diagnosis and treatment of non-autoimmune diabetes. This project is the first large-scale implementation ...
Detailed Description
The TRANSLATE project is an integrative project with multifaceted goals, that can be broken down into two main columns. The foundation for both columns is the WGS analysis in a clinical diagnostic set...
Eligibility Criteria
Inclusion
- Any case of non-T1D defined as debut \>30 years of age, OR debut \<30 years of age AND negative autoantibodies
- Any case of diabetes diagnosed in pregnancy (obstetric departments)
Exclusion
- Age \<18 years
- Inability to provide informed consent
Key Trial Info
Start Date :
May 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2027
Estimated Enrollment :
6500 Patients enrolled
Trial Details
Trial ID
NCT05368220
Start Date
May 6 2022
End Date
May 31 2027
Last Update
May 17 2022
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark
2
Herlev Hospital
Herlev, Denmark
3
Steno Diabetes Center Copenhagen
Herlev, Denmark
4
Hillerød Hospital
Hillerød, Denmark